IRD Price / Book | Opus Genetics, Inc.

Opus Genetics, Inc. (IRD) Price / Book

2025-12-31: Price/Book Ratio 9.15.
2025-09-30: Price/Book Ratio 17.85.
2025-06-30: Price/Book Ratio 3.22.
2025-03-31: Price/Book Ratio 8.79.

Historical market capitalization divided by filed shareholder equity.

Available history: 2010-12-31 to 2025-12-31
Data captured: 2026-09-04

Historical Price/Book Ratio

Date	Price/Book Ratio
2025-12-31	9.15
2025-09-30	17.85
2025-06-30	3.22
2025-03-31	8.79
2024-12-31	5.59
2024-09-30	1
2024-06-30	0.98
2024-03-31	1.09
2023-12-31	1.45
2023-09-30	1.51
2023-06-30	2.42
2023-03-31	1.9
2022-12-31	1.59
2022-09-30	3.52
2022-06-30	2.64
2022-03-31	3.6
2021-12-31	3.16
2021-09-30	4.33
2021-06-30	3.95
2021-03-31	6.47
2019-09-30	2.8
2019-06-30	6.09
2019-03-31	6.17
2018-09-30	423.1
2018-06-30	188.08
2018-03-31	153.7
2017-12-31	183.44
2017-09-30	218.63
2017-06-30	245.64
2017-03-31	53,095.39
2016-12-31	93.51
2016-09-30	1,387.9
2016-06-30	1,618.02
2016-03-31	1,962.14
2015-12-31	1,816.89
2015-09-30	2,547.95
2015-06-30	2,468.01
2015-03-31	2,686.12
2014-12-31	2,253.27
2014-09-30	2,423.46
2014-06-30	2,454.63
2014-03-31	3,266.62
2013-12-31	2,844.76
2013-09-30	2,947.82
2013-06-30	4,598.68
2013-03-31	2,121.7
2012-12-31	1,863.97
2012-09-30	4,926.88
2012-06-30	1,910.43
2012-03-31	2,801.72
2011-12-31	1,624.4
2011-09-30	4,495.3
2011-06-30	4,938.45
2010-12-31	4,352.37

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
RELMADA THERAPEUTICS, INC. (RLMD)	United States	$0.406B	-11.92
Arcturus Therapeutics Holdings Inc. (ARCT)		$0.402B	-2.05
GALECTIN THERAPEUTICS INC (GALT)	United States	$0.399B	-11.06
ARS Pharmaceuticals, Inc. (SPRY)	United States	$0.414B	-3.70
Atea Pharmaceuticals, Inc. (AVIR)	United States	$0.414B	-2.26
Turn Therapeutics Inc. (TTRX)	United States	$0.397B	-25.68
DiaMedica Therapeutics Inc. (DMAC)	United States	$0.423B	-10.11
PROTHENA CORP PUBLIC LTD CO (PRTA)	Ireland	$0.428B	-11.53
Rezolute, Inc. (RZLT)	United States	$0.382B	-6.45
CYPHERPUNK TECHNOLOGIES INC. (CYPH)	United States	$0.438B	-75.63